Human Microbiome Therapeutic Drugs Market - Global Outlook and Forecast 2023-2027

Report ID: 612728 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Human Microbiome Therapeutic Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Human Microbiome Therapeutic Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Human Microbiome Therapeutic Drugs Overall Market Size
    2.1 Global Human Microbiome Therapeutic Drugs Market Size: 2021 VS 2027
    2.2 Global Human Microbiome Therapeutic Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Human Microbiome Therapeutic Drugs Players in Global Market
    3.2 Top Global Human Microbiome Therapeutic Drugs Companies Ranked by Revenue
    3.3 Global Human Microbiome Therapeutic Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Human Microbiome Therapeutic Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Human Microbiome Therapeutic Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Human Microbiome Therapeutic Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Human Microbiome Therapeutic Drugs Market Size Markets, 2021 & 2027
        4.1.2 FMT
        4.1.3 Microbiome Drugs
        4.1.4 Others
    4.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
        4.2.1 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Human Microbiome Therapeutic Drugs Market Size, 2021 & 2027
        5.1.2 Stomach
        5.1.3 Oral
        5.1.4 Respiratory Tract
        5.1.5 Others
    5.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
        5.2.1 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Human Microbiome Therapeutic Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
        6.2.1 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Human Microbiome Therapeutic Drugs Revenue, 2016-2027
        6.3.2 US Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.3.3 Canada Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.3.4 Mexico Human Microbiome Therapeutic Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Human Microbiome Therapeutic Drugs Revenue, 2016-2027
        6.4.2 Germany Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.3 France Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.4 U.K. Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.5 Italy Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.6 Russia Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.4.8 Benelux Human Microbiome Therapeutic Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Human Microbiome Therapeutic Drugs Revenue, 2016-2027
        6.5.2 China Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.5.3 Japan Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.5.4 South Korea Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.5.6 India Human Microbiome Therapeutic Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Human Microbiome Therapeutic Drugs Revenue, 2016-2027
        6.6.2 Brazil Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.6.3 Argentina Human Microbiome Therapeutic Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, 2016-2027
        6.7.2 Turkey Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.7.3 Israel Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Human Microbiome Therapeutic Drugs Market Size, 2016-2027
        6.7.5 UAE Human Microbiome Therapeutic Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 Rebiotix
        7.1.1 Rebiotix Corporate Summary
        7.1.2 Rebiotix Business Overview
        7.1.3 Rebiotix Human Microbiome Therapeutic Drugs Major Product Offerings
        7.1.4 Rebiotix Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.1.5 Rebiotix Key News
    7.2 Seres Therapeutics
        7.2.1 Seres Therapeutics Corporate Summary
        7.2.2 Seres Therapeutics Business Overview
        7.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Major Product Offerings
        7.2.4 Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.2.5 Seres Therapeutics Key News
    7.3 Vedanta Biosciences
        7.3.1 Vedanta Biosciences Corporate Summary
        7.3.2 Vedanta Biosciences Business Overview
        7.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Major Product Offerings
        7.3.4 Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.3.5 Vedanta Biosciences Key News
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Corporate Summary
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Major Product Offerings
        7.4.4 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.4.5 Bristol-Myers Squibb Key News
    7.5 Johnson and Johnson
        7.5.1 Johnson and Johnson Corporate Summary
        7.5.2 Johnson and Johnson Business Overview
        7.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Major Product Offerings
        7.5.4 Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.5.5 Johnson and Johnson Key News
    7.6 Takeda
        7.6.1 Takeda Corporate Summary
        7.6.2 Takeda Business Overview
        7.6.3 Takeda Human Microbiome Therapeutic Drugs Major Product Offerings
        7.6.4 Takeda Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.6.5 Takeda Key News
    7.7 ENTEROME Bioscience
        7.7.1 ENTEROME Bioscience Corporate Summary
        7.7.2 ENTEROME Bioscience Business Overview
        7.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Major Product Offerings
        7.4.4 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue in Global (2016-2021)
        7.7.5 ENTEROME Bioscience Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Human Microbiome Therapeutic Drugs Market Opportunities & Trends in Global Market
    Table 2. Human Microbiome Therapeutic Drugs Market Drivers in Global Market
    Table 3. Human Microbiome Therapeutic Drugs Market Restraints in Global Market
    Table 4. Key Players of Human Microbiome Therapeutic Drugs in Global Market
    Table 5. Top Human Microbiome Therapeutic Drugs Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Human Microbiome Therapeutic Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Human Microbiome Therapeutic Drugs Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Human Microbiome Therapeutic Drugs Product Type
    Table 9. List of Global Tier 1 Human Microbiome Therapeutic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Human Microbiome Therapeutic Drugs Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Human Microbiome Therapeutic Drugs Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022-2027
    Table 30. Rebiotix Corporate Summary
    Table 31. Rebiotix Human Microbiome Therapeutic Drugs Product Offerings
    Table 32. Rebiotix Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 33. Seres Therapeutics Corporate Summary
    Table 34. Seres Therapeutics Human Microbiome Therapeutic Drugs Product Offerings
    Table 35. Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 36. Vedanta Biosciences Corporate Summary
    Table 37. Vedanta Biosciences Human Microbiome Therapeutic Drugs Product Offerings
    Table 38. Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 39. Bristol-Myers Squibb Corporate Summary
    Table 40. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product Offerings
    Table 41. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 42. Johnson and Johnson Corporate Summary
    Table 43. Johnson and Johnson Human Microbiome Therapeutic Drugs Product Offerings
    Table 44. Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 45. Takeda Corporate Summary
    Table 46. Takeda Human Microbiome Therapeutic Drugs Product Offerings
    Table 47. Takeda Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
    Table 48. ENTEROME Bioscience Corporate Summary
    Table 49. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product Offerings
    Table 50. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Human Microbiome Therapeutic Drugs Segment by Type
    Figure 2. Human Microbiome Therapeutic Drugs Segment by Application
    Figure 3. Global Human Microbiome Therapeutic Drugs Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Human Microbiome Therapeutic Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Human Microbiome Therapeutic Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Human Microbiome Therapeutic Drugs Revenue in 2020
    Figure 8. By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 12. US Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 16. Germany Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 17. France Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 24. China Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 28. India Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 30. Brazil Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue Market Share, 2016-2027
    Figure 33. Turkey Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2016-2027
    Figure 37. Rebiotix Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Takeda Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Human Microbiome Therapeutic Drugs Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Microbiome Therapeutic Drugs Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Microbiome Therapeutic Drugs Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports